People who receive certain blood products are recommended to receive hepatitis B vaccine
The following groups are recommended to receive hepatitis B vaccine because of their increased risk of infection through blood products:15
- people with clotting disorders who receive blood product concentrates
- people with recurrent transfusion requirements
- people with underlying immunocompromising conditions who receive blood products
All blood donors in Australia are screened for hepatitis B using tests for hepatitis B surface antigen and nucleic acid amplification. This has greatly decreased the incidence of transfusion-related hepatitis B virus infection.
Adult-formulation hepatitis B vaccine should be given in a 3-dose schedule. See Table. Monovalent hepatitis B vaccines for adolescents and adults in Vaccines, dosage and administration.